The human Microbiome is the aggregate of all microbiota (e.g. bacteria, archaea, fungi, protists and viruses) that reside on or within human tissues and bio fluids, including the skin, mammary glands, placenta, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, biliary tract, and gastrointestinal tract. Nowadays, Microbiome is
Overture Life has a total of 24 patents globally, out of which 2 have been granted. Of these 24 patents, more than 62% patents are active. The United States of America is where Overture Life has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, United
Emergo Therapeutics has a total of 29 patents globally, out of which 7 have been granted. Of these 29 patents, more than 75% patents are active. The United States of America is where Emergo Therapeutics has filed the maximum number of patents, followed by Europe (EPO), Australia, Canada and Japan.
Pinetree Therapeutics has a total of 26 patents globally, out of which 8 have been granted. Of these 26 patents, more than 69% patents are active. The USA is where Pinetree Therapeutics has filed the maximum number of patents, followed by Europe, Australia and Canada. Parallelly, Korea (South) seems to
AIRY3D has a total of 25 patents globally, out of which 6 have been granted. Of these 25 patents, more than 64% patents are active. The United States of America is where AIRY3D has filed the maximum number of patents, followed by Europe (EPO). Parallelly, the United States of America
MEND Nutrition has a total of 5 patents globally, out of which 5 have been granted. Of these 5 patents, more than 40% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of MEND Nutrition. MEND Nutrition
Kojin Therapeutics has a total of 4 patents globally, out of which 1 have been granted. Of these 4 patents, all the patents are active. The United States of America is where Kojin Therapeutics has filed all the patents. Parallelly, United States of America seems to be the main focused
Mahana Therapeutics has a total of 51 patents globally, out of which 2 have been granted. Of these 51 patents, more than 70% patents are active. The United States of America is where Mahana Therapeutics has filed the maximum number of patents, followed by Europe, Korea (South) and Japan. Parallelly,
Atarraya has a total of 3 patents globally, out of which 1 have been granted. Of these 3 patents, more than 66% patents are active. The United States of America and Europe (EPO) are where Atarraya has filed their all patents. Parallelly, The United States of America seems to be
Acesis has a total of 3 patents globally, out of which 2 have been granted. Of these 3 patents, more than 100% patents are active. The United States of America, Australia, and Europe (EPO) are where Acesis has filed all of patents. Parallelly, The United States of America seems to
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.